Hyaluronan Pregnancy and Breastfeeding Warnings
Brand names: Hymovis, Monovisc, Orthovisc
Medically reviewed by Drugs.com. Last updated on Nov 20, 2023.
Hyaluronan Pregnancy Warnings
Safety has not been established.
US FDA pregnancy category: Not assigned.
Risk Summary: Safety and effectiveness of this drug have not been established in pregnancy.
US FDA pregnancy category Not Assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion of the data supporting that summary, and relevant information to help health care providers make prescribing decisions and counsel women about the use of drugs during pregnancy. Pregnancy categories A, B, C, D and X are being phased out.
Hyaluronan Breastfeeding Warnings
Safety has not been established.
Excreted into human milk: Unknown
Excreted into animal milk: Data not available
Comments:
-The effects in the nursing infant are unknown.
See also
References for pregnancy information
- (2004) "Product Information. Orthovisc (hyaluronan)." Ortho Biotech Inc
References for breastfeeding information
- (2004) "Product Information. Orthovisc (hyaluronan)." Ortho Biotech Inc
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
